-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, GdetzD+lBUIPR0M4vzJN+eVGf2Jr8ZEHLXXy7jx+CO8lq04CFCngb8mIdxGyUVxi /UlyeyOCjnb+JJB8Krlifw== 0001032210-01-000047.txt : 20010123 0001032210-01-000047.hdr.sgml : 20010123 ACCESSION NUMBER: 0001032210-01-000047 CONFORMED SUBMISSION TYPE: 424B3 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20010116 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OXIS INTERNATIONAL INC CENTRAL INDEX KEY: 0000109657 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 941620407 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: SEC FILE NUMBER: 333-40970 FILM NUMBER: 1508848 BUSINESS ADDRESS: STREET 1: 6040 N CUTTER CIRCLE STE 317 CITY: PORTLAND STATE: OR ZIP: 97217 BUSINESS PHONE: 5032833911 MAIL ADDRESS: STREET 1: 6040 N CUTTER CIRCLE STE 317 CITY: PORTLAND STATE: OR ZIP: 97217 FORMER COMPANY: FORMER CONFORMED NAME: DDI PHARMACEUTICALS INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: DIAGNOSTIC DATA INC /DE/ DATE OF NAME CHANGE: 19850312 424B3 1 0001.txt FORM 424B3 Registration No. 333-40970 Filed pursuant to Rule 424(c) and Rule 424(b)(3) (Filed pursuant to Rule 424(b)(3) voluntarily because additions are not substantive) PROSPECTUS SUPPLEMENT (To Prospectus filed as part of Amendment No. 1 to Registration Statement on Form S-3 on December 21, 2000) ----------------------- This Prospectus Supplement supplements the Prospectus relating to the resale of 4,360,003 shares of Common Stock, par value $0.001 per share, of OXIS International, Inc. (the "Company") by certain stockholders of the Company, which Prospectus was filed as part of the Company's Amendment No. 1 to the Registration Statement on Form S-3 (Registration No. 333-40970) on December 21, 2000. The date of this Prospectus Supplement is January 16, 2001. ----------------------- The facing page of the Prospectus is hereby amended to read as follows: "PROSPECTUS OXIS INTERNATIONAL, INC. 4,360,003 Shares of Common Stock ($0.001 par value) The Offering: Shares of common stock offered by selling stockholders............4,360,003 Offering Price..........On December 22, 2000, the closing sale price of OXIS common stock on the Nasdaq Stock Market was $ 15/32 per share. Nasdaq National Market Symbol..........................................OXIS The Company will not receive proceeds from these sales of common stock. Our common stock involves a high degree of risk. See "Risk Factors" beginning on page 3. Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed upon the adequacy or accuracy of this prospectus. Any representation to the contrary is a criminal offense. The date of this prospectus is December 22, 2000." -----END PRIVACY-ENHANCED MESSAGE-----